These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 29633513

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer.
    Zheng X, Huang M, Xing L, Yang R, Wang X, Jiang R, Zhang L, Chen J.
    Mol Cancer; 2020 Apr 07; 19(1):73. PubMed ID: 32264877
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. E2F1 transcriptionally regulates CCNA2 expression to promote triple negative breast cancer tumorigenicity.
    Lu Y, Su F, Yang H, Xiao Y, Zhang X, Su H, Zhang T, Bai Y, Ling X.
    Cancer Biomark; 2022 Apr 07; 33(1):57-70. PubMed ID: 34366326
    [Abstract] [Full Text] [Related]

  • 5. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
    Guo GC, Wang JX, Han ML, Zhang LP, Li L.
    Cell Oncol (Dordr); 2017 Apr 07; 40(2):157-166. PubMed ID: 28054302
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer.
    Li M, Li A, Zhou S, Lv H, Yang W.
    J Hematol Oncol; 2019 Feb 08; 12(1):14. PubMed ID: 30736840
    [Abstract] [Full Text] [Related]

  • 8. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
    Jiang HL, Sun HF, Gao SP, Li LD, Hu X, Wu J, Jin W.
    Oncotarget; 2015 Jun 30; 6(18):16352-65. PubMed ID: 25970785
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase.
    Bayraktar R, Pichler M, Kanlikilicer P, Ivan C, Bayraktar E, Kahraman N, Aslan B, Oguztuzun S, Ulasli M, Arslan A, Calin G, Lopez-Berestein G, Ozpolat B.
    Oncotarget; 2017 Feb 14; 8(7):11641-11658. PubMed ID: 28036267
    [Abstract] [Full Text] [Related]

  • 12. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
    Hamurcu Z, Ashour A, Kahraman N, Ozpolat B.
    Oncotarget; 2016 Mar 29; 7(13):16619-35. PubMed ID: 26918606
    [Abstract] [Full Text] [Related]

  • 13. TCOF1 upregulation in triple-negative breast cancer promotes stemness and tumour growth and correlates with poor prognosis.
    Hu J, Lai Y, Huang H, Ramakrishnan S, Pan Y, Ma VWS, Cheuk W, So GYK, He Q, Geoffrey Lau C, Zhang L, Cho WCS, Chan KM, Wang X, Rebecca Chin Y.
    Br J Cancer; 2022 Jan 29; 126(1):57-71. PubMed ID: 34718356
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. BET degrader exhibits lower antiproliferative activity than its inhibitor via EGR1 recruiting septins to promote E2F1-3 transcription in triple-negative breast cancer.
    Liu N, Wang S, Li M, Zhao N, Wang D, Zhang R, Yu M, Zhao L, Zhang S, Han F, Zhao Y, Liu Q.
    Pharmacol Res; 2024 Oct 29; 208():107377. PubMed ID: 39209080
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Identification of differentially expressed genes between triple and non-triple-negative breast cancer using bioinformatics analysis.
    Zhai Q, Li H, Sun L, Yuan Y, Wang X.
    Breast Cancer; 2019 Nov 29; 26(6):784-791. PubMed ID: 31197620
    [Abstract] [Full Text] [Related]

  • 18. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
    Chen LL, Zhang ZJ, Yi ZB, Li JJ.
    Br J Cancer; 2017 Jun 27; 117(1):78-88. PubMed ID: 28571042
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z, Meng Q, Pan A, Wu X, Cui J, Wang Y, Li L.
    Oncotarget; 2017 Mar 21; 8(12):19455-19466. PubMed ID: 28038450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.